Application of Baricitinib in Dermatology

    Jingya Zhang, Fei Qi, Jie Dong, Yaqi Tan, Ling Gao, Fang Liu
    Image of study
    TLDR Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.
    Baricitinib, a first-generation JAK1/2 inhibitor, has been approved for treating rheumatoid arthritis but is now being explored for its potential in treating various dermatological conditions such as atopic dermatitis, psoriasis, vitiligo, and alopecia areata. Recent studies, including clinical trials and case reports from the past five years, have shown promising results, particularly in the treatment of alopecia areata. The review discusses the application, efficacy, side effects, precautions, and limitations of baricitinib in these skin diseases, with a detailed examination of its mechanism in alopecia areata, suggesting it as a new treatment option for skin conditions unresponsive to conventional drugs.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 11 results

    Related Research

    2 / 2 results